BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS • US09075A1088
8.72 USD
+0.06 (+0.69%)
At close: Feb 24, 2026
8.72 USD
0 (0%)
After Hours: 2/24/2026, 4:30:02 PM
Overall BVS gets a fundamental rating of 4 out of 10. We evaluated BVS against 185 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.
1. Profitability
1.1 Basic Checks
- In the past year BVS was profitable.
- In the past year BVS had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
- Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
- BVS has a Return On Assets of 1.11%. This is in the better half of the industry: BVS outperforms 74.59% of its industry peers.
- BVS's Return On Equity of 4.71% is fine compared to the rest of the industry. BVS outperforms 76.22% of its industry peers.
- BVS has a Return On Invested Capital of 6.62%. This is in the better half of the industry: BVS outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BVS's Profit Margin of 1.39% is fine compared to the rest of the industry. BVS outperforms 73.51% of its industry peers.
- Looking at the Operating Margin, with a value of 8.03%, BVS is in the better half of the industry, outperforming 74.59% of the companies in the same industry.
- In the last couple of years the Operating Margin of BVS has declined.
- Looking at the Gross Margin, with a value of 67.76%, BVS is in the better half of the industry, outperforming 73.51% of the companies in the same industry.
- BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BVS is destroying value.
- BVS has more shares outstanding than it did 1 year ago.
- BVS has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.33, we must say that BVS is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of BVS (1.33) is comparable to the rest of the industry.
- The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
- BVS has a better Debt to FCF ratio (6.22) than 76.76% of its industry peers.
- A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.93, BVS is doing worse than 81.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.33 |
ROIC/WACC0.61
WACC10.87%
2.3 Liquidity
- BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
- BVS has a Current ratio of 1.74. This is in the lower half of the industry: BVS underperforms 68.11% of its industry peers.
- BVS has a Quick Ratio of 1.14. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.14, BVS is doing worse than 71.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
- The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
- BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.58%.
- Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
- Based on estimates for the next years, BVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.45% on average per year.
- BVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.25% yearly.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5Y17.45%
Revenue Next Year0.15%
Revenue Next 2Y3.42%
Revenue Next 3Y4.42%
Revenue Next 5Y5.25%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 14.78, the valuation of BVS can be described as correct.
- Compared to the rest of the industry, the Price/Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 88.65% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 26.64. BVS is valued slightly cheaper when compared to this.
- With a Price/Forward Earnings ratio of 10.86, the valuation of BVS can be described as very reasonable.
- 94.59% of the companies in the same industry are more expensive than BVS, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 27.75. BVS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.78 | ||
| Fwd PE | 10.86 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 89.73% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 96.22% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.5 | ||
| EV/EBITDA | 10.83 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- BVS's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%
5. Dividend
5.1 Amount
- BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.72
+0.06 (+0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-17 2026-03-17/amc
Inst Owners74.45%
Inst Owner Change2.12%
Ins Owners2.5%
Ins Owner Change0.55%
Market Cap721.67M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (75.46%)
Short Float %2.62%
Short Ratio5.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.78 | ||
| Fwd PE | 10.86 | ||
| P/S | 1.28 | ||
| P/FCF | 13.5 | ||
| P/OCF | 12.88 | ||
| P/B | 4.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.83 |
EPS(TTM)0.59
EY6.77%
EPS(NY)0.8
Fwd EY9.21%
FCF(TTM)0.65
FCFY7.41%
OCF(TTM)0.68
OCFY7.76%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.35
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.33 |
F-Score8
WACC10.87%
ROIC/WACC0.61
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5Y17.45%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.15%
Revenue Next 2Y3.42%
Revenue Next 3Y4.42%
Revenue Next 5Y5.25%
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.72%
EBIT Next 5Y10.4%
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 4 / 10 to BVS.
What is the valuation status for BVS stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 4 / 10.
What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 14.78 and the Price/Book (PB) ratio is 4.34.
What is the financial health of BIOVENTUS INC - A (BVS) stock?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.